Systematic Review and Meta-analysis of the Association of Acute Kidney Injury with the Concomitant Use of Vancomycin and Piperacillin-Tazobactam in Children
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review and Meta-analysis of the Association of Acute Kidney Injury with the Concomitant Use of Vancomycin and Piperacillin-Tazobactam in Children
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 12, Pages -
Publisher
American Society for Microbiology
Online
2019-10-04
DOI
10.1128/aac.01572-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem
- (2019) Tao Zhang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime
- (2019) Henry T. Quach et al. PEDIATRIC BLOOD & CANCER
- Effect of concomitant vancomycin and piperacillin–tazobactam on frequency of acute kidney injury in pediatric patients
- (2019) Kaitlyn M Buhlinger et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit
- (2019) Soyoung Kang et al. PLoS One
- Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children
- (2019) Emily L. Joyce et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults
- (2018) Megan K. Luther et al. CRITICAL CARE MEDICINE
- Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam
- (2018) Manal Abouelkheir et al. PEDIATRICS INTERNATIONAL
- Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications
- (2018) Erin F. Barreto et al. PHARMACOTHERAPY
- Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin–Tazobactam or Cefepime: A Cohort Study
- (2018) Kathryn M Cook et al. Journal of the Pediatric Infectious Diseases Society
- Incidence of acute kidney injury among critically ill patients with brief empiric use of anti-pseudomonal beta-lactams with vancomycin
- (2018) Diana J Schreier et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin associated acute kidney injury in pediatric patients
- (2018) Brady S. Moffett et al. PLoS One
- Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults
- (2017) Ahmad Kaddourah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam*
- (2017) Maya R. Holsen et al. Pediatric Critical Care Medicine
- Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients
- (2017) Lisa K. LeCleir et al. PEDIATRIC PULMONOLOGY
- Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children
- (2017) Kevin J. Downes et al. JAMA Pediatrics
- Systematic Review and Meta-Analysis of Acute Kidney Injury Associated with Concomitant Vancomycin and Piperacillin/tazobactam
- (2016) Drayton A. Hammond et al. CLINICAL INFECTIOUS DISEASES
- A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury
- (2016) Stuart L. Goldstein et al. KIDNEY INTERNATIONAL
- Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis
- (2016) Christopher A. Giuliano et al. PHARMACOTHERAPY
- Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy
- (2015) Chad A. Knoderer et al. ANNALS OF PHARMACOTHERAPY
- Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam
- (2014) Lindsey D. Burgess et al. PHARMACOTHERAPY
- Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
- (2014) Diane M. Gomes et al. PHARMACOTHERAPY
- AKI in Hospitalized Children: Epidemiology and Clinical Associations in a National Cohort
- (2013) S. M. Sutherland et al. Clinical Journal of the American Society of Nephrology
- A review of renal disease in cystic fibrosis
- (2013) Dilip Nazareth et al. Journal of Cystic Fibrosis
- Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population
- (2013) Jennifer A. Pratt et al. PEDIATRIC BLOOD & CANCER
- Acute Kidney Injury and Increasing Nephrotoxic-Medication Exposure in Noncritically-Ill Children
- (2011) B. S. Moffett et al. Clinical Journal of the American Society of Nephrology
- Etiology of Septicemia in Children With Acute Leukemia
- (2011) Qing Ye et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Incidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in Children
- (2010) Susan McKamy et al. JOURNAL OF PEDIATRICS
- Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case–control analysis
- (2009) David J. Askenazi et al. PEDIATRIC NEPHROLOGY
- Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective
- (2008) Stuart L. Goldstein et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria
- (2008) Frans B. Plötz et al. INTENSIVE CARE MEDICINE
- Acute kidney injury in children
- (2008) Sharon Phillips Andreoli PEDIATRIC NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More